| Old Articles: <Older 4621-4630 Newer> |
|---|
 |
InternetNews
November 25, 2004
Michael Singer |
Oracle Stages a Proxy War In its latest pitch to take over its rival, Oracle said it has initiated plans for a proxy fight this spring -- insisting that its $24 offer is "best and final."   |
BusinessWeek
December 6, 2004
Manjeet Kripalani |
How Reliable Is Reliance? Cracks are showing in the Indian behemoth Reliance Industries Ltd, and investors are fretting. |
BusinessWeek
December 6, 2004
Robert Barker |
Wynn Resorts: Snake Eyes For Investors? One of the hottest stocks is Wynn Resorts, the vehicle that serial casino impresario Steve Wynn is using to finance the development of his two latest properties. |
BusinessWeek
December 6, 2004
Gene G. Marcial |
A Beautiful Buy At Saks? One stock that several pros are high on -- but that the Street doesn't care about -- is Saks, operator of some 350 luxury and traditional department stores. The stock has been hammered since April, when it nearly hit $18; it's now at $13.39. |
BusinessWeek
December 6, 2004
Amy Borrus |
No More Breaks For The Big Board Why the SEC should stand by its plan to loosen the NYSE's hold on trading |
BusinessWeek
December 6, 2004
Gene G. Marcial |
Boston Scientific: Anemic -- For Now Boston Scientific is far from robust -- since its summer recall of 100,000 coronary stents and since its lowered fourth-quarter profit forecast. Analysts quickly cut estimates, driving shares down from 46 in May to 33.36 on Nov. 23. |
BusinessWeek
December 6, 2004
Gene G. Marcial |
Why There's New Life At Bioenvision Bioenvision's leading product, Clofarabine, for treating leukemia in children, may get Food & Drug Administration approval soon. Is the stock a good buy? |
InternetNews
November 24, 2004
Michael Singer |
PeopleSoft 'Poison Pill' Hearing on Ice A Delaware Chancery Court judge wants to hear PeopleSoft's board explain their decision to ignore Oracle's $24 per share offer. |
The Motley Fool
November 24, 2004
W.D. Crotty |
Talking Turkey With Hormel Jenny-O turkey profits prop-up Hormel's fourth quarter results. The company is up 12.6% over the last 52 weeks. |
The Motley Fool
November 24, 2004
Rich Duprey |
Maytag Gives Employees the Spin The appliance maker freezes pay and asks workers to quit, but rewards its executives with stock options. Apparently the company believes the cost savings will be working, as it is predicting earnings to be $1.50 to $1.60 per share. |
| <Older 4621-4630 Newer> Return to current articles. |
